Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Timothy Simon Nursey 04 August 2025 no description of principal activity 00580809 2025-03-31 00580809 2024-03-31 00580809 core:CurrentFinancialInstruments 2025-03-31 00580809 core:CurrentFinancialInstruments 2024-03-31 00580809 core:ShareCapital 2025-03-31 00580809 core:ShareCapital 2024-03-31 00580809 core:SharePremium 2025-03-31 00580809 core:SharePremium 2024-03-31 00580809 core:RetainedEarningsAccumulatedLosses 2025-03-31 00580809 core:RetainedEarningsAccumulatedLosses 2024-03-31 00580809 core:Goodwill 2024-03-31 00580809 core:PatentsTrademarksLicencesConcessionsSimilar 2024-03-31 00580809 core:Goodwill 2025-03-31 00580809 core:PatentsTrademarksLicencesConcessionsSimilar 2025-03-31 00580809 core:ComputerEquipment 2024-03-31 00580809 core:ComputerEquipment 2025-03-31 00580809 bus:OrdinaryShareClass1 2025-03-31 00580809 bus:OrdinaryShareClass2 2025-03-31 00580809 bus:OrdinaryShareClass3 2025-03-31 00580809 2024-04-01 2025-03-31 00580809 bus:FilletedAccounts 2024-04-01 2025-03-31 00580809 bus:SmallEntities 2024-04-01 2025-03-31 00580809 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 00580809 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 00580809 bus:Director1 2024-04-01 2025-03-31 00580809 core:Goodwill core:TopRangeValue 2024-04-01 2025-03-31 00580809 core:ComputerEquipment 2024-04-01 2025-03-31 00580809 core:ComputerEquipment core:TopRangeValue 2024-04-01 2025-03-31 00580809 2023-04-01 2024-03-31 00580809 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 00580809 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 00580809 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 00580809 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 00580809 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 00580809 bus:OrdinaryShareClass3 2023-04-01 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 00580809 (England and Wales)

NURSEY & SON LTD

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

NURSEY & SON LTD

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

NURSEY & SON LTD

STATEMENT OF FINANCIAL POSITION

As at 31 March 2025
NURSEY & SON LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 March 2025
Note 2025 2024
£ £
Fixed assets
Intangible assets 4 17 17
Investment property 6 510,215 510,215
510,232 510,232
Current assets
Debtors 7 4,224 3,851
Cash at bank and in hand 8 231,624 288,774
235,848 292,625
Creditors: amounts falling due within one year 9 ( 5,391) ( 26,474)
Net current assets 230,457 266,151
Total assets less current liabilities 740,689 776,383
Provision for liabilities ( 90,484) ( 3,800)
Net assets 650,205 772,583
Capital and reserves
Called-up share capital 10 24,000 24,000
Share premium account 4,500 4,500
Profit and loss account 621,705 744,083
Total shareholders' funds 650,205 772,583

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Nursey & Son Ltd (registered number: 00580809) were approved and authorised for issue by the Director. They were signed on its behalf by:

Timothy Simon Nursey
Director

04 August 2025

NURSEY & SON LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
NURSEY & SON LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Nursey & Son Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 12 Upper Olland Street, Bungay, Suffolk, NR35 1BQ, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Intangible assets

Intangible assets are stated at cost or valuation, net of amortisation and any provision for impairment. Amortisation is provided on all intangible assets at rates to write off the cost or valuation of each asset over its expected useful life as follows:

Goodwill 4 years straight line
Trademarks, patents and licences not amortised
Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment 25 % reducing balance
4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Investment property

Investment property is initially recognised at cost, which includes the purchase cost and any directly attributable expenditure. Subsequently it is measured at fair value at each reporting date with changes in fair value recognised in profit or loss. Deferred taxation is provided on these gains at the rate expected to apply when the property is sold.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Critical accounting judgements and key sources of estimation uncertainty

In the application of the Company’s accounting policies, the director is required to make judgements that have a significant impact on the amounts recognised. The following are the critical judgements that the director has made in the process of applying the Company’s accounting policies and that have the most significant effect on the amounts recognised in the financial statements.

3. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including the director 2 2

4. Intangible assets

Goodwill Trademarks, patents
and licences
Total
£ £ £
Cost
At 01 April 2024 1,000 17 1,017
At 31 March 2025 1,000 17 1,017
Accumulated amortisation
At 01 April 2024 1,000 0 1,000
At 31 March 2025 1,000 0 1,000
Net book value
At 31 March 2025 0 17 17
At 31 March 2024 0 17 17

5. Tangible assets

Computer equipment Total
£ £
Cost
At 01 April 2024 11,780 11,780
At 31 March 2025 11,780 11,780
Accumulated depreciation
At 01 April 2024 11,780 11,780
At 31 March 2025 11,780 11,780
Net book value
At 31 March 2025 0 0
At 31 March 2024 0 0

6. Investment property

Investment property
£
Valuation
As at 01 April 2024 510,215
As at 31 March 2025 510,215

Valuation

The 2025 valuations were made by T Nursey, a director of the company based upon valuations carried out by professional valuers, on an open market value for existing use basis.

7. Debtors

2025 2024
£ £
Trade debtors 3,174 0
Prepayments 0 324
Other debtors 1,050 3,527
4,224 3,851

8. Cash and cash equivalents

2025 2024
£ £
Cash at bank and in hand 231,624 288,774

9. Creditors: amounts falling due within one year

2025 2024
£ £
Trade creditors 2,463 2,465
Accruals 2,928 2,747
Taxation and social security 0 20,557
Other creditors 0 705
5,391 26,474

10. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
6,850 Ordinary Class A shares of £ 1.00 each 6,850 6,850
10,883 Ordinary Class B shares of £ 1.00 each 10,883 10,883
6,267 Ordinary Class C shares of £ 1.00 each 6,267 6,267
24,000 24,000

The profit and loss account is the accumulated profit of the company since inception, along with the fair value movement of the investment property. The distributable amount is £331,855 (2024: £456,117) , non distributable amount is £287,965 (2024: £287,965)